Published on 11 May 2023 on Zacks via Yahoo Finance
Scynexis (SCYX) Reports Q1 Loss, Misses Revenue Estimates
Scynexis (SCYX) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to loss of $0.51 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 10.71%. A quarter ago, it was expected that this pharmaceutical company would post a loss of $0.50 per share when it actually produced a loss of $0.29, delivering a surprise of 42%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.